₹828.00
+2.11%NSE close, 16 Nov 2026
+14.99%
REMUS PHARMACEUTICALS L is a small cap company, listed on NSE SME under the symbol REMUS. At ₹828.00 a share, the market values the whole company at ₹976 crore. NSE SME is the exchange's platform for small and medium companies, which report their results every half year.
In FY26, it reported sales of ₹854 crore and a net profit of ₹37 crore, an operating margin of 6.6%. Over the last three years, sales grew 166.6% a year and net profit grew 63.3% a year.
The market values the company at 23.7 times its profit over the last twelve months and 1.82 times its book value; its return on equity is 7.7% and it has almost no borrowings.
Promoters hold 70.95% of the shares. Foreign institutions hold 5.10%, and domestic institutions, mutual funds among them, 0.43%.
Over the past year the share price has risen 2.1%, and it is 20.3% below its 52-week high.
Listed on NSE SME, the platform for small and medium companies: its shares trade in large lots and often thinly, so the price can move sharply on a few trades, and companies file results every half year.
₹ crore. Consolidated figures where the company filed them, standalone otherwise (marked S).
| Line | 6M to Mar 2023 S | 6M to Sep 2023 | 6M to Mar 2024 | Sep 2024 | 6M to Mar 2025 | 6M to Sep 2025 | 6M to Mar 2026 | 6M to Sep 2026 |
|---|
Transcript
Audio Recording
A media release dated November 03, 2026
| Sales | 24.6 | 29.0 | 183 | 273 | 348 | 400 | 453 | 614 |
|---|---|---|---|---|---|---|---|---|
| Expenses | 18.8 | 19.8 | 165 | 252 | 323 | 373 | 424 | 584 |
| Operating profit | 5.7 | 9.3 | 18.5 | 20.5 | 24.5 | 26.9 | 29.8 | 29.9 |
| Operating margin | 23.4% | 31.9% | 10.1% | 7.5% | 7.1% | 6.7% | 6.6% | 4.9% |
| Other income | 0.7 | 1.7 | 3.7 | 2.9 | 2.6 | 2.9 | 3.8 | 4.1 |
| Interest | 0.2 | 0.1 | 0.4 | 0.7 | 0.6 | 0.7 | 0.8 | 0.8 |
| Depreciation | 0.4 | 0.4 | 0.5 | 0.4 | 1.2 | 1.3 | 1.5 | 1.5 |
| Profit before tax | 5.9 | 10.4 | 23.6 | 22.3 | 25.4 | 27.9 | 31.3 | 31.8 |
| Tax | 1.4 | 2.6 | 3.3 | 3.5 | 4.8 | 6.3 | 6.7 | 7.1 |
| Net profit | 4.4 | 5.7 | 15.9 | 14.0 | 16.0 | 17.5 | 19.5 | 21.8 |
| EPS (₹) | 42.49 | 41.51 | 110.50 | 23.78 | 34.92 | 18.33 | 20.86 | 20.92 |
₹ crore, financial years to March.
| Line | FY23 S | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Sales | 45.0 | 213 | 620 | 854 |
| Expenses | 34.5 | 185 | 575 | 797 |
| Operating profit | 10.6 | 27.8 | 45.7 | 56.7 |
| Operating margin | 23.4% | 13.1% | 7.4% | 6.6% |
| Other income | 1.6 | 5.4 | 5.0 | 6.7 |
| Interest | 0.2 | 0.5 | 1.5 | 1.5 |
| Depreciation | 0.5 | 0.9 | 1.9 | 2.8 |
| Profit before tax | 11.4 | 31.8 | 47.3 | 59.2 |
| Tax | 2.9 | 5.9 | 8.9 | 13.0 |
| Net profit | 8.5 | 21.5 | 29.1 | 37.0 |
| EPS (₹) | 83.24 | 152.01 | 65.21 | 39.19 |
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY23 | FY24 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|---|
| From operations | 5.3 | 3.6 | 7.0 | 18.2 | 7.6 |
| From investing | −15.2 | −8.9 | −10.6 | −15.0 | −7.0 |
| From financing | 11.8 | 24.4 | 6.1 | 1.5 | −2.4 |
| Spent on fixed assets | – | – | −4.0 | −14.6 | 0 |
| Free cash flow | – | – | 3.0 | 3.6 | 7.6 |
Margins, returns, debt, tax and cash.
| Line | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Net margin | 18.9% | 10.1% | 4.7% | 4.3% |
| Operating margin | 23.4% | 13.1% | 7.4% | 6.6% |
| Return on equity | – | – | 11.4% | 10.5% |
| Return on capital employed | – | – | 17.6% | 16.2% |
| Return on assets | – | – | 6.7% | 6.4% |
| Debt to equity | – | – | 0.08 | 0.07 |
| Interest coverage | 50.60 | 67.30 | 33.40 | 41.20 |
| Debt to assets | – | – | 0.05 | 0.04 |
| Current ratio | – | – | 1.82 | 1.98 |
| Quick ratio | – | – | 1.40 | 1.49 |
| Cash ratio | – | – | 0.06 | 0.08 |
| Asset turnover | – | – | 1.43 | 1.48 |
| Fixed asset turnover | – | – | 90.83 | 150.55 |
| Inventory turnover | – | – | 10.30 | 10.30 |
| Receivables turnover | – | – | 5.70 | 6.10 |
| Gross margin | – | – | 14.1% | 13.1% |
| Cash from operations to profit | 62.0% | 17.0% | 24.0% | 49.0% |
| Effective tax rate | 25.5% | 18.4% | 18.8% | 22.0% |
Record date for the purpose of Interim Dividend is 07-Nov-2026.
Board of Directors at its meeting held on November 03, 2026, declared Interim Dividend of Rs. 1.00 per equity share.
Outcome of Board Meeting held on November 03, 2026
Schedule of meet
A copy Scrutinizer report and voting results for Postal Ballot
Scrutinizer Report and Voting results of 11th Annual General Meeting
Proceedings of Annual General Meeting held on September 29, 2026
Record date for the purpose of Dividend is 22-Sep-2026.
Notice of Annual General Meeting to be held on September 29, 2026
Notice of Postal Ballot
Proposed incorporation of a Subsidiary in Dominican Republic